Abstract
Despite prompt revascularization of acute myocardial infarction (AMI), substantial myocardial injury may occur, in part a consequence of ischaemia reperfusion injury (IRI). There has been considerable interest in therapies that may reduce IRI. In experimental models of AMI, sodium nitrite substantially reduces IRI. In this doubleblind randomized placebo controlled parallel-group trial, we investigated the effects of sodium nitrite administered immediately prior to reperfusion in patients with acute ST-elevation myocardial infarction (STEMI).
Original language | English |
---|---|
Pages (from-to) | 1255-1262 |
Number of pages | 8 |
Journal | European Heart Journal |
Volume | 35 |
Issue number | 19 |
Early online date | 17 Mar 2014 |
DOIs | |
Publication status | Published - May 2014 |
Bibliographical note
FundingThis study was funded by the UK Medical Research Council. Funding to pay the Open Access publication charges for this article was provided by the University of Aberdeen.
Acknowledgements
We would like to thank our patients and the staff of the cardiology and radiology/cardiac MRI departments at all sites. We are grateful for the support of the staff at the Centre for Healthcare Randomised Trials at the University of Aberdeen
Keywords
- acute myocardial infarction
- ischaemia-reperfusion injury
- cardioprotection
- nitrite
Fingerprint
Dive into the research topics of 'Intravenous sodium nitrite in acute ST-elevation myocardial infarction: a randomized controlled trial (NIAMI)'. Together they form a unique fingerprint.Profiles
-
Seonaidh Cotton
- School of Medicine, Medical Sciences & Nutrition, Health Services Research Unit (HSRU) - Senior Trial Manager
- School of Medicine, Medical Sciences & Nutrition, Centre for Healthcare Randomised Trials (CHaRT)
Person: Academic Related - Management
-
Dana Dawson
- School of Medicine, Medical Sciences & Nutrition, Cardiometabolic Disease
- School of Medicine, Medical Sciences & Nutrition, Applied Medicine - Chair in Cardiovascular Medicine
- Institute of Medical Sciences
Person: Clinical Academic
-
Graeme MacLennan
- School of Medicine, Medical Sciences & Nutrition, Health Services Research Unit (HSRU) - Director (CHaRT)
- School of Medicine, Medical Sciences & Nutrition, Centre for Healthcare Randomised Trials (CHaRT)
- Institute of Applied Health Sciences
Person: Academic, Academic Related - Research